Cardiac and behavioural trends in toddler pain distress responses across early development.

Sci Rep

Department of Psychology, OUCH Laboratory, York University, 4700 Keele St, 2038 Sherman Health Sciences Building, Toronto, ON, M3J1P3, Canada.

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In the second year of life, the brain undergoes rapid maturation, allowing young children to progress from relying mainly on their caregiver for comfort during distress to acquiring cognitive, motor, and emotional skills necessary for self-regulation of distress. This longitudinal, naturalistic observational study examined developmental patterns in pain-related distress responding during routine immunizations across the second year of life via cardiac and behavioural measures of pain-related distress. Respiratory Sinus Arrhythmia (RSA) and Face, Legs, Activity, Crying, and Consolability (FLACC) scores were collected at 4 epochs (Baseline, Needle, 1 min post-needle, and 2 min post-needle) during toddlers' 12-, 18-, and 24-month vaccination visits (N = 223). No significant developmental changes in RSA were found. FLACC was most variable at 12 months. FLACC responding to pain significantly diminished with age such that toddler's reactivity decreased, and regulatory rate exhibited a notable increase from 12 to 18 months. In 18- and 24-month-olds, pain behaviours returned to baseline levels by the third minute after vaccination, whereas in 12-month-olds, they remained elevated. These findings suggest that the second year of life marks a period of substantial development in distress regulation that mainly occurs between 12 and 18 months. With increasing age, toddlers' initial response to an acute pain stimulus decreases while their capacity for regulation increases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12215970PMC
http://dx.doi.org/10.1038/s41598-025-05421-2DOI Listing

Publication Analysis

Top Keywords

second year
12
year life
12
cardiac behavioural
8
pain-related distress
8
distress
6
behavioural trends
4
trends toddler
4
pain
4
toddler pain
4
pain distress
4

Similar Publications

Severe emphysema impairs lung function and quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD). Despite optimized medical treatment and rehabilitation, some patients require lung volume reduction interventions (endoscopic or surgical). This study evaluates one-year outcomes of patients managed at the Emphysema Clinic of CHU Liège.

View Article and Find Full Text PDF

Introduction: Injectable extended-release buprenorphine is an effective treatment for opioid use disorder (OUD), but injection site reactions (ISRs) are common treatment-emergent adverse events that may impact patient comfort, adherence, and outcome. This report examines the clinical presentation, prevalence, and management of Sublocade-related ISRs through two case studies and a review of existing literature.

Case Presentation: We present two cases of ISRs in patients receiving extended-release buprenorphine, Sublocade.

View Article and Find Full Text PDF

Background: Bridge preparation skills are a vital component of dental education and require specific techniques. This study aimed to develop and evaluate 3D printed teeth for use in defect-oriented bridge preparation and pre-prosthetic exercises in dental training, addressing the limited customization and lack of integrated workflows found in commercial typodont teeth. The null hypothesis stated that 3D printed teeth offered no advantage over established typodont training methods for bridge preparation.

View Article and Find Full Text PDF

Immune checkpoint inhibitors combined with chemotherapy in conversion therapy for stage IV gastric cancer: a multicenter retrospective cohort study.

Cancer Immunol Immunother

September 2025

Department of Gastric Surgery, Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Hangzhou, 310022, Zhejiang, China.

Objectives: To evaluate the efficacy of combining PD-1 inhibitors with chemotherapy in conversion therapy for patients with stage IV gastric cancer and to determine the populations most likely to benefit from this regimen.

Methods: Data from patients with stage IV gastric cancer who received conversion therapy with PD-1 inhibitors combined with chemotherapy between January 2018 and December 2022 at multiple centers were retrospectively reviewed. Patients who underwent conversion surgery were categorized into a surgery group, while those who did not were placed into a palliative group.

View Article and Find Full Text PDF

We herein report two cases of immunotactoid glomerulopathy (ITG) associated with multiple myeloma treated with daratumumab-based regimens. The first patient was an 81-year-old woman with severe renal insufficiency and IgAκ multiple myeloma (MM) that progressed to end-stage renal disease despite administering daratumumab-based therapy. The second patient, a 69-year-old man with smoldering MM, showed a favorable response to daratumumab-based treatment, with a resolution of nephrotic proteinuria.

View Article and Find Full Text PDF